2020-04829. Bulk Manufacturer of Controlled Substances Application: S&B Pharma, Inc.; Correction  

  • Start Preamble

    ACTION:

    Notice of application; correction.

    SUMMARY:

    The Drug Enforcement Administration (DEA) published a document in the Federal Register on November 22, 2019, concerning a notice of application. As that document correctly indicated, the applicant, S&B Pharma, Inc., DBA Norac Pharma, 405 South Motor Avenue, Azusa, California 91702-3232 applied to be registered as a bulk manufacturer of a number of controlled substances, to include applying for authorization in order to synthetically manufacture using drug code 7360 (marihuana). However, on the notice of application published, drug code 7360 was inadvertently identified and listed as Gamma Hydroxybutyric Acid instead of Marihuana.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    Correction

    In the Federal Register of November 22, 2019, in FR Doc. 2019-25402 (84 FR 64563), on page 64564, correct the listing of drug code 7360 to be identified as Marihuana, as is shown below.

    Controlled substanceDrug codeSchedule
    Marihuana7360I
    Start Signature

    Dated: February 11, 2020.

    William T. McDermott,

    Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2020-04829 Filed 3-9-20; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
03/10/2020
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application; correction.
Document Number:
2020-04829
Pages:
13931-13931 (1 pages)
Docket Numbers:
Docket No. DEA-582
PDF File:
2020-04829.pdf